tucatinib in her2 breast cancer with leptomeningeal metastases
Published 3 years ago • 362 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:36
the tbcrc049 trial for treating leptomeningeal metastases in her2 breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
1:45
dr. chien on tucatinib in her2 breast cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
0:36
tucatinib & trastuzumab /- chemo or pembrolizumab in unresectable or metastatic her2 gi cancers
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
3:08
the benefits of tucatinib in her2 breast cancer
-
1:27
dr. murthy on future of tucatinib in her2 breast cancer
-
2:10
treating cns metastases in her2 breast cancer
-
0:52
the significance of tucatinib trastuzumab as a chemotherapy-free option for her2 metastatic btc
-
0:51
dr. hamilton discusses tucatinib in her2 breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
1:45
dr. kalinsky on neratinib and tucatinib in her2 metastatic breast cancer
-
2:01
her2climb: tucatinib in combination w/ capecitabine & trastuzumab
-
7:38
tucatinib plus trastuzumab & capecitabine for patients with her2-positive breast cancer & brain mets